Compare AWI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AWI | CRL |
|---|---|---|
| Founded | 1860 | 1947 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.9B | 7.8B |
| IPO Year | 2006 | 2000 |
| Metric | AWI | CRL |
|---|---|---|
| Price | $200.28 | $161.35 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 12 |
| Target Price | $203.14 | ★ $205.27 |
| AVG Volume (30 Days) | 483.3K | ★ 870.4K |
| Earning Date | 02-24-2026 | 02-18-2026 |
| Dividend Yield | ★ 0.68% | N/A |
| EPS Growth | ★ 23.00 | N/A |
| EPS | ★ 6.97 | N/A |
| Revenue | $1,600,200,000.00 | ★ $4,023,704,000.00 |
| Revenue This Year | $14.13 | N/A |
| Revenue Next Year | $6.91 | $1.70 |
| P/E Ratio | $28.74 | ★ N/A |
| Revenue Growth | ★ 15.10 | N/A |
| 52 Week Low | $122.37 | $91.86 |
| 52 Week High | $206.08 | $228.88 |
| Indicator | AWI | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 60.55 | 24.97 |
| Support Level | $181.90 | $148.34 |
| Resistance Level | $206.05 | $218.69 |
| Average True Range (ATR) | 4.34 | 9.59 |
| MACD | 1.27 | -6.24 |
| Stochastic Oscillator | 76.12 | 17.02 |
Armstrong World Industries Inc. designs, innovates, and manufactures ceiling and wall solutions in the Americas. The company manufactures and sources products made of numerous materials, including mineral fiber, fiberglass, metal, felt, wood, resin, wood fiber, and glass-reinforced-gypsum. It also manufactures ceiling suspension system (grid) products through a joint venture with Worthington Industries, Inc., called Worthington Armstrong Venture (WAVE). The company's reportable operating segments include Mineral Fiber, Architectural Specialties, and Unallocated Corporate. A majority of its revenue is generated from the Mineral Fiber segment, which produces suspended mineral fiber and fiberglass ceiling systems. Geographically, it derives maximum revenue from the United States.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.